Venture
Cellanome, Inc.
Latest Form D 2026-06-22- CIK 1886462
- State CA
- Biotechnology
- 5 Form D offerings since 2021-10-05
- Total sold
- $290M
- across 5 offerings
- Rounds
- 5
- Form D offerings since 2021-10-05
- Latest round
- $75.9M
- 2026-06-22 · 021-588010
- Investors
- 22
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-06-22 · $75.9M
- 2021-10-05$2M021-415748
- 2021-12-06$21M021-423743
- 2022-08-05$40.7M021-454964
- 2024-01-29$150M021-503792
- 2026-06-22$75.9M021-588010
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($150M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-588010 | First filed2026-06-22 | Latest2026-06-22 | Sought$75.9M | Sold$75.9M | Investors22 | Exemptions506(b) |
| 021-503792 | First filed2024-01-29 | Latest2024-01-29 | Sought$150M | Sold$150M | Investors20 | Exemptions506(b) |
| 021-454964 | First filed2022-08-05 | Latest2023-03-21 | Sought$40.7M | Sold$40.7M | Investors11 | Exemptions506(b) |
| 021-423743 | First filed2021-12-06 | Latest2021-12-06 | Sought$21M | Sold$21M | Investors2 | Exemptions506(b) |
| 021-415748 | First filed2021-10-05 | Latest2021-10-05 | Sought$2M | Sold$2M | Investors17 | Exemptions506(b) |
Who backs Cellanome, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-06-22
| Name | Relationship | Clarification |
|---|---|---|
| Omead Ostadan | RelationshipExecutive Officer, Director | Clarification— |
| Rowan Chapman | RelationshipDirector | Clarification— |
| Mostafa Ronaghi | RelationshipDirector | Clarification— |
| Jay Flatley | RelationshipDirector | Clarification— |
| Sandesh Patnam | RelationshipDirector | Clarification— |
| Mehdi Khodadad | RelationshipExecutive Officer | ClarificationSecretary |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2021-10-05
- Latest filing
- 2026-06-22
Who backs Cellanome, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗